Just to clarify my position on INX-189. I feel BMY won't test INX-189 beyond the 200mg. dose, and it will be combined with their late stage NS5A, due to potential safety issues seen amongst the purine class. I still contend purine nukes are the only class which could be used as a monotherapy.
Market Data 
Markets 
AI
